GSK-204947

Study Sponsor: GSK

Study Title

A phase III study to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with overactive bladder

Medicine or Vaccine (generic name)

OnabotulinumtoxinA

Sponsor Identification Number

204947

Trial Registry Identification Number(#'s)

NCT02820844

Medical Condition

Urinary Bladder, Overactive

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2020